Thought Leadership Series:

Life Sciences Digi Marketing Summit

June 17-19, 2020

Princeton, NJ

Event Overview

Life Sciences Digi Marketing Summit is a gathering of the industries top thought leaders that are focused on attaining real solutions to everyday challenges in the digital marketing arena. Join this interactive summitt to address the current regulations, technologies, compliance, strategic digital marketing techniques and issues that the life sciences face as stepping into the next decade.

Our speaker faculty will share how to you can determine the way your organizationn should continue to evolve and shapie the future of digital marketing for Life Sciences.
While there are other events that focus on digital marketing that have similar sessions year after year, there aren’t any that are focusing specifically on understanding how to properly prepare on how to execute the strategy your company is needing to compete with the customer centric needs of the future.

Hilton East Brunswick


3 Tower Center Blvd.
East Brunswick, NJ 08816

(732) 828-2000

Hotel Website

About the Chairperson


Dr. Matthew T. Roe has been a faculty member at Duke University School of Medine and the Duke Clinical Research Institute (DCRI) since 1999. As a senior investigator at the DCRI, he has been the principal investigator for numerous phase II-IV cardiovascular clinical trials and is currently a co-principal investigator for the ADAPTABLE trial—the first large-scale pragmatic trials being conducted in the PCORnet network. He has also served in leadership roles for several observational registries focusing upon the treatment and outcomes of patients with cardiovascular disease and has served as the Director of the DCRI Clinical Research Fellowship since 2010.

Featured Speakers


Craig Lipset

Head of Clinical Innovation


Jeff Kingsley

Chief Executive Officer
IACT Health 


Dawn Anderson

Managing Director, Life Sciences Strategy and Operations, R&D Practice


Ross Friedberg

General Counsel & Chief Privacy Officer
Doctor on Demand

Top Reasons to Attend

  1. Network and learn with the top marketing professionals from leading pharmaceutical, biotechnology, and medical device companies
  2. Understand how to adapt your programs to multichannel and global approaches
  3. Learn the best practices to implement and enhance your various marketing strategies
  4. Identify tools and strategies using technology and digital media that can enhance your marketing efforts
  5. Discuss how to ensure that your organization is following all regulatory and compliance standards while developing an effective campaign

Attendee Profile

  • Marketing Director (Head, Global, Regional, Senior)
  • Chief Marketing Officer
  • Digital Marketing (Head, Global, Director)
  • Account Management
  • Patient Marketing
  • Brand Marketing / Brand Team
  • Chief Communications Officer
  • Chief Strategy Officer
  • Multichannel Marketer
  • Digital Communications
  • Public Relations
  • Communications and Development
  • Market Strategy
  • Consumer Engagement


May 13th, 2020 | Day 1

8:00 AM - 9:00 AM

Registration & Continental Breakfast

9:00 AM - 9:15 AM

Conference Opening Remarks

9:15 AM - 10:00 AM

Gene Therapy Value Propositions

Oscar Segurado, MD, PhD - Chief Medical Officer
ASC Therapeutics

10:00 AM - 10:45 AM

Creating a Best-in-Class Safety/PV Department – Key Differences between Big Pharma and Small Biotech in Rare Disease

Judy T. Hsiung, DPM - Vice President, Safety and Pharmacovigilance

10:45 AM - 11:00 AM

Morning Networking Break

11:00 AM - 12:00 PM

PANEL: Access to Orphan Drugs – Fast Tracking, Early Access and Expanded Access

12:00 PM - 1:00 PM

Networking Lunch

1:00 PM - 1:45 PM

Collaborating Around Rare Disease

Jon Kaskey - Regional Vice President, Business Partnerships

1:45 PM - 2:45 PM

Patient Diversity – Increasing Awareness Among and Participants from the Latino, African American and Native American Communities in Rare Disease Clinical Trials


2:45 PM - 3:00 PM

Afternoon Networking Break

3:00 PM - 4:00 PM

Critical Considerations in the Transition to Automated Systems Implementation

Israel Gutierrez - Vice President, Pharmacovigilance & Drug Safety

4:00 PM - 4:45 PM

Digital Tools for the Benefit-Risk Optimization of Medicines

Michael Forstner-Dambenois - Senior Vice President - Head of Pharmacoepidemiology & Risk Management

4:45 PM - 5:00 PM

Day 1 Closing Remarks



Ronald Walls

The CSPC Pharmaceutical Group

US Head of Operations, & Business Development, Vice President Clinical Development Medical Affairs


Dakota Fisher-Vance

Young Adult Cancer Connection

Founder (Also Patient Advocacy Manager, Horizon Therapeutics)


Dan Donovan






Before 3/27/20



Register Before Event



Register at Event




Before 3/27/20



Register Before Event



Register at Event


Register 2 Attendees, Get 1 Complimentary Registration*!

Interested in sending groups of 7 or more? Contact us directly for pricing.



Contact Amy Chapman at (561) 571-7687




Why Become Board Certified in Medical Affairs?


Certification is becoming an important factor in the healthcare industry in general. A survey of over 1000 key opinion leaders (KOLs) found that over 90% preferred medical affairs professionals who had a Board Certified Medical Affairs Specialist (BCMAS) designation.

Several pharmaceutical companies also look at certification as a way to assess whether an individual possesses the skills and knowledge required for successful performance in a medical affairs role. Why are companies looking for this assurance? They want to hire the best of the best. By becoming board certified in your field of expertise, and by maintaining BCMAS, you are saying that you:

  • Have met standards that have been established and verified by a credible, accrediting body.
  • Are dedicated to maintaining quality of excellence in your profession.

These are powerful statements that speak volumes about you as a professional and the company or organization you represent. Board certification demonstrates that you are committed to your profession and that you want to continue to learn and grow.
Studies have shown that individuals who are certified in their field have higher salaries and better promotion opportunities.

Top 5 Reasons Why You Should Certify with the ACMA:

  1. Accredited: The ACMA is recognized nationally & internationally as a true mark of quality and excellence in the pharmaceutical industry for medical affairs professionals. The ACMA is accredited by the International Association for Continuing Education & Training (ANSI/IACET) which is the gold standard for certification & training around the world. Our program is administered and analyzed using the highest industry standards and state-of-the-art psychometric methodologies.
  2. Distinguish Yourself: Because ACMA offers multiple but related certificates, you can more readily become certified in more than one specialty, making you more valuable and marketable in the field.
  3. Go International: ACMA certification is widely accepted throughout the US as well as internationally with 25% of BCMAS graduates coming from outside the US.
  4. Expand Your Network: Once certified by ACMA you automatically become a member of the 75,000+ strong ACMA organization and gain access to a multitude of benefits, including discounts on continuing education, leadership opportunities, and access to a mentor to help you get ahead.
  5. Be on the cutting edge: ACMA board certification in medical affairs is the future of the life sciences and pharmaceutical industry.

Interested in BCMAS?

By attending any DGE/ACMA conference, receive 10% off of BCMAS registration.

Already BCMAS Certified? Receive 10% off your conference registration!